Metgen Revenue and Competitors
Estimated Revenue & Valuation
- Metgen's estimated annual revenue is currently $5.3M per year.
- Metgen's estimated revenue per employee is $155,000
Employee Data
- Metgen has 34 Employees.
- Metgen grew their employee count by -3% last year.
Metgen's People
| Name | Title | Email/Phone |
|---|
Metgen Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $4.2M | 27 | -7% | N/A | N/A |
#10 | $10.1M | 65 | 5% | N/A | N/A |
What Is Metgen?
We design and market novel enzymatic solutions for the most challenging of industrial conditions to meet our customers need. MetGen's enzymes – MetZyme® – are industrial, highly-active, natural catalysts that accelerate chemical reactions. They can survive in harsh industrial environments which enables novel applications and combination with other enzymes. MetGen products are protected by international patents. Offering customized projects to meet customer's specific needs, MetGen uses advances in genetic engineering and microbiology to adapt enzymes to harsh industrial conditions and to handle a variety of lignocellulosic substrates. MetGen has achieved successful industrial trials with sector leaders in the forest and renewable chemicals. In 2014 MetGen Oy has won the Best in BioFuel / BioEnergy category for the Global Cleantech Cluster Association (GCCA) 2014 Later Stage Award. The GCCA's Global Top 10 Winners represent the best of the association's 52 member clusters and over 10,000 member companies.
keywords:N/A
N/A
Total Funding
34
Number of Employees
$5.3M
Revenue (est)
-3%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Metgen News
... Enzyme Solutions, Enzymatic Deinking Technologies, LLC, Biocatalysts, Metgen, Denykem and Tex Biosciences (P) Ltd., among others.
Policies underwritten by Metropolitan General Insurance Company (MetGen) do not have a six-month waiting period for cruciate ligament issues...
MetGen, a Finnish startup developing bio-based materials, and Phase Change Solutions, a U.S. maker of "phase-change materials," "largely fit...
Other Companies in Kaarina
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $5.3M | 34 | -3% | N/A |
#2 | $22.3M | 91 | 5% | N/A |